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The ultimate goal of toxicologic investigations of both natural and man-made fibrous and
nonfibrous particles is to provide essential input for the assessment of potential human risks
from exposure to these materials. The development of risk assessment procedures for airborne
particles has evolved over the years. The earliest assessments for naturally occurring materials
used direct human observations and incorporated safety factors to arrive at allowable human
exposures. More recently, there has been a need to assess the potential risk associated with
production and use of certain man-made materials for which human data are not available or are
inadequate. For these materials, it has been necessary to assess human risks using data
obtained from studies conducted in laboratory animals and with cells or tissues. During the last
several decades, it has been suggested that data on the mechanisms by which particles cause
disease could be used to reduce the uncertainty in estimates of human risks of particle
exposures. This article provides comments on the use of mechanistic data in the risk
assessment process and suggestions for increasing the successful development and use of
mechanistic data in risk assessments conducted in the future. - Environ Health Perspect
105(Suppl 5):1363-1372 (1997)
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Particulate matter has long been identified
as noteworthy when considering air quality
and its impact on health. Attention initially
focused on occupational exposure in dusty
trades such as mining, quarrying, and stone
masonry. Early in this century, the obser-
vance ofpulmonary disease associated with
asbestos exposure raised concern about
fibers as a special kind ofparticulate mater-
ial. In this article, the term particulate
matter (PM) is used for both nonfibrous
and fibrous particulates unless specifically
noted otherwise. PM was considered to be
toxicity, cancer
involved in debilitating pulmonary diseases
that were manifested by irritation, inflam-
mation, fibrosis, and functional impairment.
Perhaps the best example is silicosis, the spe-
cific form ofpneumoconiosis attributed to
exposure to crystalline silica. Other pneu-
moconioses were attributed to specific dusts
and named accordingly. Some dusts, initially
termed inert or nuisance dusts and now
called particulates not otherwise classified or
regulated, produced effects that were
reversible ifexposures were controlled to
modestlevels.
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Coincident with the steady rise in lung
cancer rates that began in the 1930s in men,
and later in women, was the awareness that
lung cancer might be associated with PM
exposures. Cigarette smoking is now known
to be the primary risk factor responsible for
the increase in lung cancer rates for men
that continued until 1990 before slowly
beginning to subside (and are continuing to
rise for women). Several other specific occu-
pations or agents are also now known risk
factors for lung cancer, including asbestos,
which is a risk factor for both lung cancer
and mesotheliomas.
Concern for lung disease associated
with occupational exposures led to early
voluntary efforts on the part of industry
and local and state authorities to control
exposures to PM. These efforts were
followed by voluntary national efforts and,
ultimately, federal statutes directed toward
controlling occupational exposures. The
passage offederal statutes for occupational
exposure was paralleled by statutes directed
toward limiting environmental exposures.
In this article, I briefly review the
development ofapproaches to characteriz-
ing human health risks ofexposure to PM
as a basis for setting exposure limits. I
then comment on how mechanistic infor-
mation is being used in the risk assess-
ment process and offer some suggestions
on how the development and utilization
of mechanistic information on PM might
be improved.
An underlying premise ofthis article is
that PM exposures should be held to the
lowest practicable level and that deter-
mination ofthis level can be greatly facili-
tated by mechanistically understanding
how and at what levels ofexposure various
chemical forms and sizes of PM affect
humans. Establishment of standards for
occupational and environmental exposures
involves use ofall ofthe available scientific
data as well as considerable judgment.
Ultimately, in most situations, there is con-
sideration ofthe anticipated health benefits
of a standard and the costs of implement-
ing it. My call for the acquisition and use
ofscientific data should not be viewed as a
call for delaying risk management decisions
in the face of convincing evidence of
human hazard. It is, however, a call for
acquiring scientific information that will
reduce the uncertainty in assessing human
risks and thus increase the certainty that
risk management decisions will produce
results in a cost-effective manner.
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Historic Development
of Exposure Guidance
and Standards
Early occupational standards for PM were
ofa voluntary nature and were developed
by industry and local and state govern-
ments. Out of these efforts came the
development ofthe American Conference
of Governmental Industrial Hygienists
(ACGIH). As early as 1946, the ACGIH
issued guidelines for airborne concentrations
ofvarious substances, including PM.
The earliest values were presented as
maximum allowable concentrations-
time-weighted average(s) (TWA), which
soon became threshold limit value(s)
(TLV)-TWA. TLV are regularly updated,
and the current values are given in the
ACGIH document Threshold Limit Values
for Chemical Substances andPhysicalAgents
and Biological Exposure Indices (1).
Supporting documentation is also available
(2) that includes brief summaries of the
basis for each ofthe TLV. In the introduc-
tion to these documents, TLV are defined:
"TLV refer to airborne concentrations of
substances and represent conditions under
which it is believed that nearly all workers
may be repeatedly exposed day after day
without adverse health effects." The TLV
documents include a number of specific
chemicals found in the air as PM. In addi-
tion, a listing is given for particulates not
otherwise classified, which was formerly
identified as nuisance dust.
The ACGIH is a professional society
and not a government agency. Nonethe-
less, its guidance is widely viewed as
authoritative and, as a result, has had sub-
stantial impact on workplace practices in
the United States and abroad.
Heightened concern for occupational
and environmental health issues beginning
in the mid-1960s gave impetus to the
passage of several major pieces of legis-
lation that established guidance for PM in
occupational and environmental settings.
Legislation included the Clean Air Act
(CAA), the Occupational Safety and
Health Act, the Mine Safety Act, the
Toxic Substances Control Act (TSCA),
Superfund, and the Resources Conser-
vation and Control Act. A review of the
details of these various statutes is beyond
the scope of this article. Note that major
authority related to occupational expo-
sures is vested in the Department of
Labor: the Mine Safety and Health
Administration is responsible for miners,
and the Occupational Safety and Health
Administration (OSHA) has more general
responsibility. Major authority related to
environmental exposure to airborne
materials is vested with the U.S. Environ-
mental Protection Agency (U.S. EPA)
under the CAA. The U.S. EPA also influ-
ences workplace practices under other
statutes, such as TSCA.
In regulating workplace exposures,
OSHA utilizes permissible exposure
limit(s) (PEL) that are very similar to TLV.
Indeed, to jump-start the development of
PEL, OSHA originally adopted as PEL the
TLV that had been established by the
ACGIH. The U.S. EPA broadly regulates
air pollutants within two separate sections
of the CAA. One of these sections covers
the criteria pollutants for which EPA must
set National Ambient Air Quality
Standard(s) (NAAQS). One ofthese crite-
ria pollutants is PM. A separate section of
the act concerns regulation ofhazardous air
pollutant(s) (HAP).
Beyond the above-mentioned agencies,
the Secretary, Department of Health and
Human Services, is responsible for prepar-
ing the Biennial Report on Carcinogens, (3)
which lists agents classified as human car-
cinogens or reasonably anticipated to be
human carcinogens. This task is conducted
by the U.S. National Toxicology Program
(NTP), which does not have regulatory
authority. However, the NTP report is fre-
quently used by other agencies as a basis
for regulatory decisions on the listed chem-
icals. On the international front, the
International Agency for Research on
Cancet (IARC) periodically prepares
monographs that report on the classifica-
tion of agents or exposure situations as to
their carcinogenic potential. The IARC
reports are frequently used by national
bodies as a basis for regulatory actions.
Risk Assessment
Approaches
Three basic approaches are used by the
above organizations in developing stan-
dards concerning human health risks from
exposure to chemicals, including PM. For
ease of communication, these approaches
are referred to hereafter as a) threshold, b)
cancer classification, and c) quantitative
estimation of risk approaches. They
evolved historically in the order listed.
ThrholdApproach
The earliest efforts to assess human health
risks of PM used a threshold model.
Examples are the TLV set by the ACGIH
forcrystalline silica and other forms ofsilica,
asbestos, and particulates not otherwise
classified. The TLV are based on informa-
tion from industrial experience, experi-
mental human and animal studies, or a
combination of all three when possible.
Obviously, human data are used to the
extent that they are available. For materials
widely used in commerce, substantial
human data may exist. For newly devel-
oped materials, human data may be in-
adequate or nonexistent, requiring heavy
reliance on laboratory animal data.
Safety factors or uncertainty factors are
used to make extrapolations from labora-
tory animal data to humans. Typically, 10-
fold factors are used to account for
interindividual variability in susceptibility,
extrapolation from animals to humans, or
extrapolation from subchronic to chronic
exposures. For example, in a subchronic
study conducted in rats, extrapolation ofa
no observed effect level from rats to
humans would involve an overall safety or
uncertainty factor of1000.
The U.S. EPA approach for developing
inhalation reference concentrations (RfC)
has many similarities to that used to
develop the TLV. Jarabek (4) recently
reviewed this methodology in detail and
defined an RfC as "an estimate (with
uncertainty spanning perhaps an order of
magnitude) of a continuous inhalation
exposure to a human population (including
sensitive subgroups) that is likely to be
without appreciable risk of deleterious
noncancer health effects during a lifetime."
The RfC methodology is being used by the
U.S. EPA to assess noncancer risks ofHAP
and other materials for which the agency
has statutory responsibility.
The U.S. EPA also uses a threshold
approach, customized to the specific
pollutant under consideration, in setting
the NAAQS for criteria pollutants. In
setting the NAAQS, the agency is charged
with protecting the general public, in-
cluding sensitive subpopulations, from
adverse health effects, with an ample
margin of safety. The ample margin of
safety is included to account for un-
certainties in current knowledge. Each
NAAQS involves four key decisions: selec-
tion ofan indicator (i.e., what is to be mea-
sured), a concentration level, an averaging
time, and a statistical form (e.g., one
exceedance [instance where standard levels
are exceeded] peryear).
The U.S. EPA has prepared an updated
criteria document and staffposition paper
on PM (5,6), and has proposed the addi-
tion ofPM 2.5 pm in aerodynamic diameter
(PM2.5) standards to complement the
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present PM<10 pim in aerodynamic
diameter (PM1o) standards (7). The pro-
posed change in the PM standards must be
considered in a historic context. The origi-
nal NAAQS for PM promulgated in 1971
was based on total suspended particulate(s)
(TSP). This represented all the PM sam-
pled with a high volume sampler [Figure 1;
(8)]. This includes particles as large as 30
to 40 pm in aerodynamic diameter.
During the late 1970s and early 1980s
researchers recognized that the TSP indica-
tor was not particularly health relevant,
since many ofthe particles included in a
TSP sample were sufficiently large that
they had a low probability ofbeing inhaled
and deposited in the respiratory tract.
In 1979 the U.S. EPAannounced that it
was beginning a review ofthe PM NAAQS.
Over the next 7 years (1979-1986), there
was extensive interaction among the scien-
tific community, the U.S. EPA staff, and
the agency's Clean Air Scientific Advisory
Committee (CASAC) as the PM NAAQS
review proceeded. The collaboration
included preparation of a criteria docu-
ment, staffpaper, and supplements to both
documents. The criteria document is an
encyclopedic compilation of all available
peer-reviewed literature on the pollutant
(PM in this case). The staffposition paper is
a critical analysis ofthe literature that is
most relevant for identifying the indicator
(TSP, PM1o, or PM25), the averaging time
(annual, 24 hr), the level ofconcentration,
and the statistical form (arithmetic average,
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etc.). The CASAC is an independent com-
mittee ofscientists charged under the CAA
with advising the U.S. EPA Administrator
on the science used to establish the
NAAQS. In 1987 the U.S. EPA changed
from the TSP indicator to a more health-
relevant PM1o indicator (9). Two standards
were set: a) an annual standard of50 pig/m3
expected arithmetic mean, averaged over 3
years, and b) a 24-hr average standard of
150 pg/m3, vwith no more than one expected
exceedance peryear.
In response to a court-ordered schedule,
in 1995 and 1996 the U.S. EPA completed
an updated criteria document and related
staffpaper on PM (5,6). As required by
the CAA, the U.S. EPA's CASAC reviewed
both documents (10,11).
An overview of the issues involved in
revising the PM standards has recently
been published (12). Following the PM1o
standard set in 1987, a number ofnew epi-
demiologic studies were published showing
an association between TSP or PM1o levels
and various indices ofmorbidity and mor-
tality. Exposure data for the TSP and
PM1o indicators were available because of
regulatory requirements for TSP measure-
ment (up until 1987) and for PM1o mea-
surement (beginning in 1987). Meager
data are available using a PM2 5 indicator.
Interpretation ofthe epidemiologic studies
is complicated by the difficulty of sepa-
rating effects of TSP, PM1o, or PM2.5
from the effects of other air pollutants
DP,gm
Accumulation mode Coarse mode
Coarse particles
Coarse fraction ofPMIO
Figure 1. Schematic of the relationship between various parameters used to describe the size distribution of air-
borne particles. Adapted from Wilson and Suh (8). Abbreviations: oy,geometric deviation; DP, diameter of particle;
MMD, mass median diameter; V, volume.
such as ozone and carbon monoxide and
confounders such as weather and cigarette
smoking. In the establishment ofNAAQS,
data from controlled exposure studies with
human subjects and experimental studies
with laboratory animals, tissues, and cells are
typically used to complement data from epi-
demiological studies. Unfortunately, in the
case ofPM10 and PM2.5, the complementary
data areverylimited.
Based on the available PM data, the U.S.
EPA staffpaper recommended the establish-
ment ofPM2,5 standards to complement the
PM1o standards (6). Specifically, the recom-
mendation was for a 24-hr average PM2.5
standard in the range of18 to 65 pg/m3 and
an annual PM2.5 standard in the range of
12.5 to 20 pg/m3. The staff also recom-
mended continued use ofa PM1o indicator:
150 pg/m3 for a 24-hr average and 40 to 50
pg/m3 for an annual standard. Nineteen of
21 CASAC members endorsed the estab-
lishment ofa PM2 5 indicator. Two indi-
viduals were opposed to the use ofa PM2.5
indicator, and were joined by two others
opposed to the setting of a PM2.5 24-hr
standard and six individuals opposed to a
PM2.5 annual standard. Individual CASAC
members expressed awide range ofopinions
as to the appropriate level for various
standards [Table 1 (11,13)].
The diversity ofopinions expressed by
CASAC members reflects the high degree
ofuncertainty in our current knowledge of
PM effects, and especially those that can be
quantitatively linked to PM2.5. These
uncertainties include a) the influence of
confounding variables such as other pollu-
tants, b) measurement errors, c) exposure
misclassification, d) the lack of under-
standing of toxicologic mechanisms to
explain the effects, e) the use of different
models in various studies, andf) the shape
ofthe exposure-response function for typi-
cal exposures currently experienced in the
United States.
In late 1996 the U.S. EPAproposed revi-
sions to the PM NAAQS (14). It was pro-
posed that the PM1o standards would be
retained; however, the one expected exceedance form ofthe 150 pg/mi 24-hr
standard would be changed to a 98th
percentile form averaged over 3 years. Most
significantly, the agency proposed new
PM2.5 standards set at 15 pg/m3 annual
mean, and 50 pg/m3 24-hr average. The
annual standard would be based on the
3-year average ofthe annual arithmetic mean
PM2 5 concentrations, spatially averaged
across an area. The 24-hr average would
be based on a 3-year average ofthe 98th
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Table 1. IARC carcinogen evaluation scheme.a
Category Human evidence Experimental animal evidence
Group 1. The agent(mixture) is (a) Sufficient No animal evidence required
carcinogenic to humans. The exposure (b) Less than sufficient Sufficient evidence and strong
circumstance entails exposures that evidence in exposed humans that
are carcinogenic to humans. the agent(mixture) acts through a
relevant mechanism of carcinogenicity
Group 2A. The agent(mixture) is probably (a) Limited None
carcinogenic to humans. The exposure (b) Limited Sufficient
circumstance entails exposures that are (c) Inadequate Sufficient and strong evidence that
probably carcinogenic to humans. the carcinogenesis is mediated
by a mechanism thatalso operates
in humans
Group 2B. The agent(mixture) is possibly (a) Limited Less than sufficient
carcinogenic to humans. The exposure (b) Inadequate Sufficient
circumstance entails exposures that are *(c) Inadequate Limited, with supporting evidence
possibly carcinogenic to humans. from other relevant data
Group 3. The agent(mixture or exposure (a) Inadequate Inadequate or limited
circumstance) is not classifiable as to its (b) Inadequate Sufficient and strong evidence that
carcinogenicity. the mechanism of carcinogenicity in
experimental animals does not
operate in humans
Group 4. The agent(mixture) is probably (a) Lack ofcarcinogenicity Lack ofcarcinogenicity
not carcinogenic to humans. (b) Inadequate Lack of carcinogenicity consistently
and strongly supported by a broad
range of other relevant data
"Adapted from IARC (13).
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Figure 2. Schematic of alternative interpretations of
reported epidemiologic relative risk (RR) findings with
regard to possible underlying PM mortality concentra-
tion-response functions. a, linear model of observed
relationship extended to a baseline risk (RR= 1.0) at
the lowest observed PM level. b, alternative interpreta-
tion using the same slope as line a extended to essen-
tially zero PM. c, an underlying functional relationship
with an initial flat segment statistically indistinguish-
able from the baseline risk (RR=1.0) until same thresh-
old is exceeded, above which the RR increases.
Adapted from the U.S. EPA (6).
percentile of24-hr PM2.5 concentrations at
each monitorwithin an area.
This U.S. EPA proposal generated
much discussion. One point ofcontroversy
is apparent from consideration ofthe expo-
sure-response functions shown schemati-
cally in Figure 2. In the exposure range of
interest, it is difficult to establish whether
there is a threshold exposure level that must
be exceeded before effects are observed. In
addition, the lack of information on the
mechanisms by which PM is causing
effects at low levels ofexposure does not
provide a mechanistic basis for selecting one
exposure-response function over another.
The choice ofa linear model ofexposure
and response including PM2.5 concen-
trations down to 5 jig/m3, compared to the
use of a threshold concentration of 18
pg/m3, is illustrated in Figure 3 (14). The
assumption that linearity extends down to
very low PM concentrations, irrespective of
the specific indicator, results in calculated
responses at PM concentrations that cannot
realistically be controlled. The choice ofthe
model has a dramatic impact on estimated
cumulative mortality, which is nearly three
times higher for the nonthreshold model
than for the threshold model.
Without question, there is need for
mechanistic information on the linkage
between various PM indicators and health
outcomes to guide future revisions of the
PM standard and, most importantly, to
guide strategies to control the most haz-
ardous PM. The present PM1o standards
and proposed new PM2.5 standards are not
chemical specific. All partides, irrespective of
their chemical composition (e.g., soil dust or
combustion emissions), are considered to be
ofequal toxicity per unit mass. Further, all
particles collected within the specified size
fraction are considered to be ofequal toxicity
per unit mass, irrespective ofwhether the
mass represents a few 1-pm diameter parti-
cles or a thousand times as many 0.1-jim
diameter partides. The large uncertainties in
our current knowledge emphasize the need
to more clearly understand the causal
mechanistic linkage between PM exposure
and health outcomes for future reviews and
revisions ofPM standards.
Despite the uncertainties noted, the
U.S. EPA has proceeded with the issuance
in mid-1997 ofa new rule for PM NAAQS
(14). The new rule establishes two new
PM2.5 standards: a) an annual standard set
at 15 pg/m3 based on the 3-year average of
annual arithmetic mean PM2.5 concentra-
tions from single or multiple community-
oriented monitors, and b) a daily standard
of65 pg/m3 based on the 3-year average of
the 98th percentile of24-hr concentrations
at each population-oriented monitor
within an area. The rule retains two PMjo
standards: a) a 24-hr PM1o standard set at
65pg/m3 for the 3-year average ofthe 99th
percentile of the 24-hr concentrations at
each monitor within an area, and b) an
annual PM1o standard set at 50 pg/m3 for
the 3-year average ofthe annual arithmeti/
mean PM1o concentration at each monitor
within an area. The new rule will be
reviewed by the Congress and will likely
result in substantial debate. Irrespective of
their position on implementation of the
new standards, it is likely that all parties to
the debate will recognize the merits of
additional focused research to provide an
improved basis for future decisions on the
regulation ofPM.
CancerClasificationApproaches
Carcinogen classification is the most
frequently identified approach; IARC and
U.S. EPA schemes are being developed
nearly concurrently (13,14). For purposes
ofbrevity, only the IARC scheme will be
illustrated (Table 1). Basically, the scheme
considers epidemiologic and laboratory ani-
mal evidence of carcinogenicity. Since
1991, IARC panels have also evaluated
mechanistic data when making a final deci-
sion as to classification. An example was the
decision to upgrade the classification ofeth-
ylene oxide from Group 2A (a probable
human carcinogen), where it had been
placed based on limited human evidence
and sufficient animal evidence), to Group 1
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Figure 3. Illustrative air quality distribution of 24-hr
PM2.5 concentrations showing (A) a frequency distribu-
tion of the number of days exceeding various 24-hr
averagePM2.5concentrations overa year; (B) estimated
mortality for nonthreshold and threshold (18 pg/m3)
concentration-response relationships; and (C) esti-
mated cumulative mortality for both relationships.
Adapted from the proposal for new PM2.5 standards
[U.S. EPA(7)].
(a human carcinogen) based on mechanistic
evidence (15). This created a somewhat
awkward situation in that Group 1 now
includes two subgroups: a large group of
agents for which there is sufficient evidence
of human carcinogenicity, and a single
agent (ethylene oxide) for which there is
limited evidence ofhuman carcinogenicity.
The IARC classification scheme does
not address the potency of carcinogens.
In short, a carcinogen is a carcinogen,
irrespective of its potency. This sharply
restricts the use of IARC data in moving
beyond what has been termed the hazard
identification stage of risk assessment to a
a fuller characterization of risk. A full
characterization of risk requires informa-
tion on the potency ofthe agent as well as
an assessment ofexposure.
QuantitativeRiskEstimation
The third approach used in assessment of
PM risk is that ofquantitative risk estima-
tion. This approach is most clearly identi-
fied with the U.S. EPA. Its use grew out of
the agency's need to quantitate the extent
ofrisk posed by various HAP (13,16-18).
The quantitative approach has its roots in
the assessment ofcancer risks with radia-
tion exposure and with the release of
radioactive materials from nuclear power
industry operations. For radiation expo-
sures, unlike chemical exposures, substan-
tial quantitative dose-cancer response data
are available for humans. Unfortunately,
neither radiation nor chemical data extend
to the low dose (or exposure) rates that are
ofgreatest interest, which necessitates the
use ofextrapolation models to estimate the
risks oflow-level exposures. This is the same
issue as discussed earlier and illustrated in
Figure 2.
Human data that quantitatively relate
cancer response to chemical exposure are
available for only a few chemicals. Thus
two major extrapolations must be made to
attempt to quantitate human cancer risk
for a majority of chemicals and for most
PM exposures: from laboratory animals to
humans, and from high levels ofexposure
to substantially lower levels ofexposure.
The U.S. EPA published guidelines for
assessing carcinogenic risk (19) and recently
proposed major revisions to the guidelines
(14). The proposed guidelines take into
account many of the suggestions made in
the National Research Council (NRC)
report Science and Judgment in Risk
Assessment (17). The guidelines build on
the substantial progress made during the
last decade in understanding the carcino-
genic risks ofchemical exposures and how
they may be assessed. The proposed guide-
lines emphasize the value of using specific
scientific information on the mode of
action ofchemicals in riskassessment, using
default options only when specific scientific
information is not available. A major
advance is the guidance for preparation ofa
narrative statement for each chemical,
which summarizes the weight ofevidence
concerning carcinogenic potential and
replaces the alphanumeric classification
previously recommended. Another major
change is the option of using alternative
models to describe the relationship
between low levels ofexposures and cancer
risk, rather than using the linearized multi-
stage model exclusively, as required by the
previous guidelines.
The proposed changes will have the
greatest impact on assessing risks of the
modest number of chemicals for which
extensive mechanistic data are available.
Examples include formaldehyde, chloro-
form, and chemicals that produce male rat-
specific kidney tumors via an a2u-globulin
mechanism (20). With case studies on
chemicals such as these, it should be possi-
ble over time to extend the approaches to
other chemicals. This includes both risk
assessment and, ofequal importance, the
acquisition ofnew mechanistic information
that can reduce uncertainty in assessing
risks, as discussed below.
Acquisition
of Mechanistic Data
For many years, scientists have attempted
to better understand how various kinds of
airborne particles cause disease. Often,
research has been conducted with a view
toward understanding the complex process
bywhich diseases develop and applying the
knowledge gained to improve disease pre-
vention, diagnosis, and treatment. In some
cases, studies have had a PM orientation,
for example, investigation ofthe character-
istics ofparticles that cause them to vary
markedly in their ability to cause disease.
To a large extent, a major motivation for
past research has been a desire to explore
the unknown. This approach to research
has led to substantial improvements in our
understanding ofpulmonary diseases and
the ways in which various toxic agents may
produce disease. In the past, relatively little
research has been explicitly directed toward
reducing uncertainties in the assessment of
human PM exposure risks. Studies have
been conducted at all levels ofbiological
organization, including populations of
occupationally or environmentally exposed
people, laboratory animals, and studies
with isolated tissues and cells. Much ofthe
current research uses the most recent
advances in molecular and cell biology.
Our current knowledge ofhow various
kinds of particles and fibers can cause
disease can be integrated as shown schemati-
cally in Figures 4 and 5 (21). These schemes
are for illustrative purposes, with recogni-
tion that some linkages are speculative and
that not all of the possible steps linking
exposure to PM and disease are included.
However, it is imperative that we periodi-
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cally integrate what we do know about the
progression oftoxicant exposure-from ini-
tial exposure to the dose oftoxicant reaching
critical molecules and cells and ultimately to
the development ofdisease.
Many advances in our knowledge have
come from a reductionist approach that
seeks to understand interactions in some
small portion of the bigger picture illus-
trated in Figures 4 and 5. In some cases,
investigators have tried to place their find-
ings within the context ofthese larger sce-
narios. Unfortunately, the focus in many
cases has been on the use ofmore refined
reductionist approaches rather than on
adequate consideration ofhow the observa-
tions fit in the larger context, or how the
information gained could be used to
improve the characterization of human
risks from exposure to specific PM.
Over time it is anticipated that an
increasingly clear picture will emerge of
the mechanisms by which PM may pro-
duce disease. However, this may not
result in improved risk assessments for
PM since all increments of improvement
in mechanistic knowledge are not ofequal
value. Information on the mode of action
ofspecific PM will be ofparticular value.
The mode of action for a toxicant is
determined by those key mechanistic
steps that link exposure to dose to disease
and are crucial in determining the shape
of the exposure-response relationship for
humans, an approach advocated by
Butterworth et al. (22).
Many of the papers presented at this
meeting reported findings from studies
conducted with only a single exposure or
dose level, as contrasted with the long-
term human exposures of greatest con-
cern. Further, the exposure (dose) levels
studied were frequently extraordinarily
highcompared with levels likely to be
encountered by humans, even under the
most extreme of plausible exposure cir-
cumstances. Thus, the studies did not
yield information readily applicable to
understanding exposure (dose)-response
relationships for likely human exposures.
Many ofthe studies, even those using the
most contemporary molecular approaches,
may primarily be providing insight into
mechanisms that are unique to the high
levels ofexposure (dose) studied and may
have very limited relevance to understand-
ing the occurrence or absence ofdisease at
likely levels ofhuman exposure. Many of
the studies might have yielded information
of much greater value if additional lower
exposure (dose) levels had been studied.
Diesel exhaust
Particulate matter
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Figure 4. Pathogenesis of lung disease in rats with chronic, high-level exposures to particles.
Understanding mechanisms at lower
levels of exposure (dose) is especially
important when the primary disease of
concern, cancer in this case, has a quantal
or dichotomous (i.e., presence or absence of
cancer) exposure (dose)-response relation-
ship over the range ofexposures intended
for extrapolations to lower levels ofexpo-
sure. For example, our ultimate interest
may be in extrapolating from an observed
incidence of 1 in 10 to an incidence as low
as 1 in 106. For reference purposes, a typi-
cal smoker has a probability ofabout 1 in
10 ofdying oflung cancer, with 9 smokers
not dying oflung cancer. The dichotomous
nature of the response even at high levels
of exposure, as in cigarette smokers, is
indicative ofsome ofthe many mechanistic
steps from exposure to the toxicant to the
development ofdisease that also manifest
dichotomous rather than continuous
responses. Alternatively, some ofthe indi-
vidual steps in the multistep process may
only be mnanifest as dichotomous functions
when observed at low levels of exposure
over long periods of time. Studies con-
ducted at high levels ofexposure may result
in a saturation ofthe system, thus masking
the dichotomous response.
The cancers of special concern for
inhaled particles are typically manifest in
increased incidence in people beginning
late in midlife. Cancer linked to exposure
to toxic agents is usually observed only after
a latent period ofseveral decades, and fre-
quently after extended periods ofexposure.
In contrast, most ofthe studies reported at
the meeting involved only a single brief
exposure to a toxicant or exposures over a
fewdays or, rarely, a fewweeks.
When exposures are ofhigh intensity
and for short periods of time, the events
observed largely involve only injury to the
system, with repair processes that are
totally overwhelmed. The dichotomous
nature ofthe cancer response in a popula-
tion may be in part a reflection of the
interplay between injury and repair at var-
ious stages in the carcinogenic process in
different individuals. When exposure and
time scenarios that minimize the opportu-
nity for repair are studied, what would
otherwise be manifest as a dichotomous
response shifts to a continuous response
function. This complicates the extrapola-
tion of findings to the long-term, low-
level exposures that are of concern for
human populations.
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Figure 5. Mechanisms ofpulmonarydisease induced bychronic high level exposure to highly biopersistentfiber. Adapted from McClellan and Hesterberg (21).
An additional point deserving mention
is the role of in vitro studies in the acquisi-
tion of information that can be used to
improve human risk assessments. In vitro
studies are one of the cornerstones of a
reductionist approach to acquiring new
insight into complex biological processes
such as the effect of inhaled particles on
humans. Moreover, the use of in vitro sys-
tems may minimize the need for in vivo
studies in laboratory animals.
One advantage of in vitro systems is
that they can be used to study biological or
pathobiological processes in isolation from
the more complex milieu of the intact
mammalian body. Ultimately, however,
the in vitro findings must be placed within
the context of that more complex in vivo
milieu. One approach to placing the in
vitro observations in context is to conduct
closely linked in vitro and in vivo studies.
Another useful approach is the use of
coculture systems that utilize epithelial cells
cultured both with and without macro-
phages. Such linkages were apparent for a
few ofthe papers presented at this meeting.
Unfortunately, observations made in vitro
with highly sophisticated experimental
techniques were not linked to the in vivo
situation in many cases.
In in vitrostudies, there is a special need
to establish the relevance ofthe exposures
(doses) to possible results in vivo. With in
vivo studies, experimental limitations
impose upper bounds on the quantity of
particles that can be delivered to the cells of
the respiratory tract. In working with in
vitro systems or in in vivo studies with
instillation or injection of mnaterials, these
experimental limitations are removed, and
it is possible to deliver to cells quantities of
particles that are many times greater than
could be found in the body under Inyplau-
sible human exposure scenario. The
researcher working with in vitro systems is
urged to perform calculations that illustrate
the relationship between the doses used in
vitro to those likely to be found in vivo in
laboratory animals and, ultimately, to
make comparisons with plausible human
exposure. When particles are delivered by
nonphysiological modes such as intratra-
cheal instillation to instantaneously achieve
a large lung burden ofPM, it is important
to recognize that the effects may differ
from a slowly accumulating burden ofPM.
The last point to be made before
concluding this discussion of past mechanis-
tic approaches is the need to remember that
our ultimate interest is in understanding and
assessing human health risks from exposure
to airborne PM. This requires that in vivo
studies with laboratory animals and in vitro
studies with tissues and cells from laboratory
animals be related back to humans. One
approach is to conduct in vitro studies with
both human and laboratory animal tissues
and cells, further clarifying the interpretation
offindings from laboratory animal in vivo
studies. Studies with human tissues, when
practical, should indude a sufficient number
ofsamples to get a sense ofthe range and
variability ofkey parameters in human
populations. An additional approach is to
study multiple laboratory animal species to
identify both similarities and differences
among laboratory species. This approach
provides an improved basis forevaluating the
likely nature ofthe human response. Several
papers presented at this meeting illustrated
clear differences in the responses ofdifferent
species to inhaled partides in the respiratory
tract. A better understanding ofthe basis for
both interspecies differences and similarities
in exposure-response relationships will
enhance our ability to estimate human risks
ofPM exposure.
Use of Mechanistic Data
I have just argued that many of our high
dose, short-term mechanistic studies exag-
gerate injury and discount repair and shift
what might be dichotomous responses to
continuous responses. This assertion has
important implications for the use ofsuch
studies in those carcinogen classification
schemes that are placing increased emphasis
on the use ofmechanistic data. Both IARC
and the NTP recently opened the door to
increased use ofmechanistic data to either
upgrade or downgrade the carcinogen clas-
sification of individual chemicals. IARC
already upgraded ethylene oxide from
Category 2A (probable human carcinogen)
to Category 1 (a human carcinogen) based
on mechanistic data in the absence of
sufficient evidence ofhuman carcinogenic-
ity. The NTP (23) has proposed classifying
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agents as "reasonably anticipated to be
human carcinogens" based on mechanistic
data in the absence of evidence of
carcinogenicity from animal bioassays.
These approaches to incorporating
mechanistic data into the carcinogen clas-
sification process have the potential for
classifying agents as carcinogens that are
only high-dose laboratory animal car-
cinogens, only high-dose carcinogens in a
single laboratory animal species, or agents
that at high doses produce some preneo-
plastic mechanistic responses but have not
been evaluated as to their carcinogenicity
in whole-animal studies. Carbon black, a
high-dose rat carcinogen, is illustrative of
the second type ofagent.
The next edition of the NTP Biennial
Report on Carcinogens will include the first
agents classified as "reasonably anticipated
to be human carcinogens" based on mech-
anistic data in the absence ofdirect animal
evidence of carcinogenicity. Most of the
agents initially considered for listing are
combustion products. Major controversy is
likely to arise when the first commercial
agent is listed as "reasonably anticipated to
be a human carcinogen" in the absence of
direct animal or human evidence. With
regard to carbon black, long-term exposure
of rats to high concentrations causes an
excess oflung cancer in rats compared to
controls (24,25). The studies of Driscoll
(26), Driscoll et al. (27), and Oberdorster
(28) provide clear evidence of a mecha-
nism ofaction for carbon black producing
lung cancer despite the fact that carbon
black does not interact directly with DNA
to produce mutations. The mechanism
involves chronic high-level exposure to car-
bon black to produce persistent inflam-
mation, with associated high levels of
cytokines and mediators, and an increased
frequency ofmutations.
An IARC panel considered the two
positive rat bioassays to be sufficient evi-
dence ofanimal carcinogenicity; despite the
mechanistic information for a high-dose,
rat-specific mechanism, IARC classified car-
bon black in Category 2A (a probable
human carcinogen) (29). I previously indi-
cated a line of reasoning that would have
placed carbon black in Category 3 (not
classifiable). The IARC panel apparently
was ofthe opinion that the currently avail-
able data did not prove that small particles
cannot cause cancer in humans. In reaching
this conclusion, the panel no doubt
considered quartz and asbestos, which do
not interact directly with DNA and are
classified by IARC as human carcinogens.
In considering the carcinogen classifi-
cation issue for carbon black, I noted the
value ofaugmenting an alphanumeric classi-
fication scheme with a narrative statement
(30). In Science andJudgment in Risk
Assessment (17), the Committee on Risk
Assessment ofHazardous Air Pollutants rec-
ommended the use ofa narrative statement
describing the evidence for an agent's car-
cinogenicity in humans. The U.S. EPA fol-
lowed this recommendation in the proposed
revision of its carcinogen risk assessment
guidelines (14).
In addition to the issues associated with
classifying agents as to their carcinogenicity,
the carcinogenic potency ofan agent should
be established in quantitative or semi-
quantitative terms. Present carcinogen clas-
sification schemes do not consider either
the likely potency of an agent or current
and anticipated levels ofhuman exposure.
Because potency is not considered, agents
that differ markedly in their potency may
be placed in the same category. Proponents
ofpresent classification schemes frequently
argue that these schemes are intended only
to provide input into the hazard identifica-
tion phase of risk analysis. This is a short-
sighted view, which results in less available
information for government and private
officials, workers, and the public at large to
use for input into decisions on the best way
to deal with possibly carcinogenic agents.
Suggestions for a
Change in Approach
The use of formalized risk analysis has
increased markedly during the past two
decades, and the methods used for risk
analysis have continually evolved. These
changes are readily apparent from
consideration ofthe 1983 NRC report, Risk
Assessment in the Federal Government:
Managing the Process (31); the 1994 NRC
report, Science and Judgment in Risk
Assessment (17); the 1986 U.S. EPA
Guidelinesfor Carcinogen Risk Assessment,
and the 1996 U.S. EPA proposed revisions
to the 1986 guidelines (14). Two inter-
related themes are apparent from a review of
both sets of documents. The first theme
relates to uncertaintyand the need to charac-
terize it for use in future research. Such feed-
back should reduce uncertainty in future risk
assessments. The need to characterize uncer-
tainty, and the opportunity to reduce it as
riskassessments are carried out in an iterative
fashion, are dominant themes ofthe 1994
NRC report. The use ofthe feedback loop,
from risk assessment to the research arena, is
schematicallydepicted in Figure 6.
A second closely related theme is the use
ofspecific scientific information to replace
default options. Default options are selected
to be conservative (i.e., more likely to over-
estimate than to underestimate risk); thus
the introduction ofscientific information
specific to the risk assessment being con-
ducted should serve to reduce uncertainty
in the specific assessment and is also likely
to reduce the estimated risk.
The acquisition of mechanistic
information is central to both themes. New
information, including mechanistic infor-
mation, will have maximum impact on
the risk assessment process when it is rele-
vant and usable in the process. In earlier
sections, I raised questions concerning the
relevance ofsome ofthe mechanistic infor-
mation obtained in the past. Information
Risk communication
Effectively communicate the total risk process and risk characterization to all stakeholders
Action Identification of research needs
Figure 6. Risk assessments can help identify research needs that, if addressed, can reduce uncertainty in
assessing risks.
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that is oflimited relevance for assessment of
human risks may in fact increase uncertainty
in the estimation ofhuman risks.
To increase the usefulness ofinformation
obtained from future research directed
toward reducing uncertainty in assessment
of human health risks from exposure to
particles, I suggest use of the following
guidelines:
* Mechanistic studies should be
prospectively designed with a clear view
as to how results ofa given study will
be used in the risk assessment process.
This can be done by stating experimen-
tal objectives in the form of testable
hypotheses that are linked to the risk
assessment process (Figure 7). In many
cases, these hypotheses will address
issues related to default options that
would otherwise be used in the absence
ofspecific scientific data.
* Exposures (doses) to be used should be
evaluated to establish their relationship
to plausible levels ofhuman exposure
and, for in vitro studies, to tissue levels
likely to be observed in in vivo studies
using realistic exposure levels. Imple-
mentation of this guideline might be
facilitated by establishing maximally
tolerated doses (U.S. EPA perspective)
or minimally toxic doses (European
Economic Community perspective) for
in vitro studies analogous to those advo-
cated for chronic toxicity and carcino-
genicity studies. This issue, as relates to
in vivo studies, has been extensively
reviewed (31-33).
* In the conduct of in vitro mechanistic
studies, use three or more dose levels of
the toxicant in addition to a control
group when practical, to achieve a gradi-
ent ofresponse relative to dose. The goal
ofsuch studies should go beyond demon-
strating an effect and its underlying
mechanism and extend to elucidating
Figure 7. Iterative approach to formulation of hypothe-
ses, development of models, and conduct of mechanis-
tic research to improve risk assessments.
how the mechanism or mechanisms are
influenced bydose anddose rate.
* When conducting short-term in vivo
studies of mechanisms of action,
investigators should use three or more
exposure levels to achieve a gradient
of response relative to exposure. The
highest exposure level should be no
higher than the highest exposure
likely to be tolerated in a 90-day expo-
sure study; the lowest level should be
the lowest practicable exposure that
yields tissue doses equivalent to the
highest levels likely to be observed in
humans. The goal of such studies
should be similar to that noted in the
previous guideline.
* When practical, observations made in
vitro with tissues or cells obtained from
laboratory animals should be extended
to human tissues or cells. When practi-
cal, samples from a sufficient number
of individuals should be evaluated to
characterize interindividual variability.
* When practical, the result ofmechanistic
studies should be presented quantita-
tively within the framework ofan expo-
sure (dose)-time-response matrix rather
than reported as yes-no phenomena.
* When interpreting mechanistic data for
use in carcinogen classification schemes
or other aspects of risk assessment,
investigators should place substantially
greater weight on data obtained over a
range ofexposure (dose) levels and longer
periods of observation. Less weight
should be given to observations made at
a single high exposure (dose) level and
with shortperiods ofobservation.
* Mechanistic data should be used for risk
assessment purposes only when they are
more likely to represent a mechanism
operative in humans at plausible levels
ofexposure.
Ultimately, whatever mechanistic data
are developed must be integrated with the
results ofanimal bioassays and whatever
human data are available to provide a
weight-of-the-evidence assessment of
human risk. The evaluation and integration
process for all ofthe various pieces ofinfor-
mation is complex and obviously involves
considerable judgment. Hill (34) provided
valuable guidance for consideration ofepi-
demiologic evidence of the relationship
between environment and disease and,
specifically, whether the evidence was one of
association or causation. The nine view-
points he related are ofconsiderable merit
for all types of evidence, not just
epidemiologic, in assessing human risks of
exposure to agents present in environmental
or occupational settings. Hill's viewpoints
(34) are paraphrased below:
* Strength: What is the strength of the
relationship between the agent or an
individual event in the pathogenesis of
the disease and the disease?
* Consistency: Has the association been
observed by different investigators, in
different types ofstudies, in both human
and laboratory animal tissues?
* Specificity: Is the association specific to
a particular PM or class ofPM, or is it
a general aspect of the disease process
not unique to any particular agent? Is
the mechanistic event obligatory with
regard to development ofdisease?
* Temporality: Where does a particular
pathogenic event fit into the linkage
between exposure to PM and occurrence
ofdisease? Does it occur early or late in
the disease process?
* Biological gradient: Is a biological gradi-
ent or an exposure (dose)-response rela-
tionship observed? What are the lower
limits for statistically detecting evidence
ofan increase in some mechanistic event
versus increasing exposure (dose)?
* Plausibility: Do the data indicate bio-
logical plausibility? In considering plau-
sibility, it is important to recall Hill's
admonishment-"What is biologically
plausible depends upon the biological
knowledge ofthe day."
* Coherence: Is a specific observation
supported or reinforced by other
observations?
* Experiment: What is the experimental
evidence? In evaluating the role ofa spe-
cific agent causing a series ofmechanis-
tic events, have adequate positive and
negative controls been experimentally
evaluated?
* Analogy: Are the same or similar
mechanistic linkages observed with
other similar PM exposures?
In my opinion, Hill (34) was advocat-
ing what we now call a weight-of-the-evi-
dence approach in which all of the
evidence is considered, as contrasted to a
strength-of-the-evidence approach that
emphasizes the use ofpositive studies. The
use ofthis kind ofrobust approach to risk
assessment is needed since new materials
with great potential value to society will
continually be discovered and commercial-
ized. It is imperative that we improve the
approaches available for evaluating the
potential risks ofthese new materials and
the processes by which they are produced
prior to introducing them into commerce.
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At the same time, there is a need to govern
against using systems that have potential for
yielding an excess offalse-positive results that
may exclude potentially valuable products
from commerce.
The above guidelines are not intended
to be either exhaustive or constraining.
They are offered to stimulate discussion as
we attempt to collectively bring more and
better science to bear in the assessment of
human health risks from exposure to a
wide range ofagents.
Summary
In this article, I briefly reviewed the
approaches used to assess human health
risks of PM exposures and the role of
mechanistic data in improving the process.
Guidelines for the development and use of
mechanistic data in the risk assessment
process are offered to stimulate discussion
ofapproaches for better links between the
acquisition and use ofmechanistic data in
the risk assessment process. In doing so, we
need to expand the statement ofParacelsus
(1493-1541): "What is there that is not
poison? All things are poison and nothing
(is) without poison. Solely the dose and the
mechanism of action determine that a
thing is or is not apoison."
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